Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-033413

General Counsel sold 3,493 shares at $3.38 ($11,810)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-13 Sale : show line 1 in the form −3,493 $3.38 $11,810 674,484 D
Open-market sales · 3,493 sh · avg $3.38 · $11,810
Loading xslF345X06/form4.xml…